FI945081L - Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon - Google Patents

Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon Download PDF

Info

Publication number
FI945081L
FI945081L FI945081A FI945081A FI945081L FI 945081 L FI945081 L FI 945081L FI 945081 A FI945081 A FI 945081A FI 945081 A FI945081 A FI 945081A FI 945081 L FI945081 L FI 945081L
Authority
FI
Finland
Prior art keywords
dry powder
suspension formulation
oral suspension
stable hydrated
cephalosporin
Prior art date
Application number
FI945081A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI945081A0 (fi
FI945081A7 (fi
Inventor
Donald A Johnson
Lorraine Wearley
Rebecca Galeos
Joel A Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI945081L publication Critical patent/FI945081L/fi
Publication of FI945081A0 publication Critical patent/FI945081A0/fi
Publication of FI945081A7 publication Critical patent/FI945081A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI945081A 1992-04-30 1993-04-30 Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformu laatioon FI945081A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87688192A 1992-04-30 1992-04-30
PCT/US1993/003856 WO1993021923A1 (en) 1992-04-30 1993-04-30 Stable hydrated cephalosporin dry powder for oral suspension formulation

Publications (3)

Publication Number Publication Date
FI945081L true FI945081L (fi) 1994-10-28
FI945081A0 FI945081A0 (fi) 1994-10-28
FI945081A7 FI945081A7 (fi) 1994-10-28

Family

ID=25368763

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945081A FI945081A7 (fi) 1992-04-30 1993-04-30 Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformu laatioon

Country Status (22)

Country Link
US (1) US5599557A (cs)
EP (1) EP0642344B1 (cs)
JP (1) JP3378004B2 (cs)
KR (1) KR100257803B1 (cs)
AT (1) ATE150310T1 (cs)
AU (1) AU674516B2 (cs)
CA (1) CA2134467A1 (cs)
CZ (1) CZ283428B6 (cs)
DE (1) DE69309052T2 (cs)
DK (1) DK0642344T3 (cs)
EE (1) EE03039B1 (cs)
ES (1) ES2099438T3 (cs)
FI (1) FI945081A7 (cs)
GR (1) GR3023516T3 (cs)
HU (1) HU215958B (cs)
NO (1) NO307594B1 (cs)
NZ (1) NZ252433A (cs)
PL (1) PL171630B1 (cs)
RU (1) RU2123863C1 (cs)
SK (1) SK279329B6 (cs)
UA (1) UA27899C2 (cs)
WO (1) WO1993021923A1 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
US8425936B2 (en) * 2003-07-21 2013-04-23 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1653925A1 (en) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
AU2005269981A1 (en) * 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US8653145B2 (en) * 2005-09-22 2014-02-18 Eaton Scientific Systems, Ltd. Method for alleviating climacteric symptoms
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008016678A2 (en) * 2006-08-01 2008-02-07 Sunesis Pharmaceuticals, Inc. Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
TW200918096A (en) * 2007-06-22 2009-05-01 Kaneka Corp Composition comprising bioactive substance
JP5364580B2 (ja) * 2007-08-22 2013-12-11 株式会社カネカ 還元型補酵素ｑ１０の製造方法、ならびに、その安定化方法
EP2566449B1 (en) * 2010-05-04 2014-10-08 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
GB202306826D0 (en) 2023-05-09 2023-06-21 Adjutec Pharma As Therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3780195A (en) * 1969-10-22 1973-12-18 Balchem Corp Encapsulation process
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4803082A (en) * 1987-10-28 1989-02-07 Warner-Lambert Company Flavor and sweetness enhancement delivery systems and method of preparation
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
NZ252433A (en) 1996-07-26
SK279329B6 (sk) 1998-10-07
NO944113D0 (no) 1994-10-28
SK131194A3 (en) 1995-07-11
JP3378004B2 (ja) 2003-02-17
CZ283428B6 (cs) 1998-04-15
HK1002407A1 (en) 1998-08-21
CZ263694A3 (en) 1995-04-12
HUT71226A (en) 1995-11-28
EP0642344A1 (en) 1995-03-15
DE69309052D1 (de) 1997-04-24
EE03039B1 (et) 1997-10-15
AU674516B2 (en) 1997-01-02
GR3023516T3 (en) 1997-08-29
ATE150310T1 (de) 1997-04-15
AU4115293A (en) 1993-11-29
UA27899C2 (uk) 2000-10-16
WO1993021923A1 (en) 1993-11-11
RU94046038A (ru) 1996-11-10
HU215958B (hu) 1999-03-29
US5599557A (en) 1997-02-04
KR100257803B1 (en) 2000-08-01
FI945081A0 (fi) 1994-10-28
RU2123863C1 (ru) 1998-12-27
DE69309052T2 (de) 1997-06-19
DK0642344T3 (da) 1997-07-07
CA2134467A1 (en) 1993-11-11
PL171630B1 (pl) 1997-05-30
EP0642344B1 (en) 1997-03-19
ES2099438T3 (es) 1997-05-16
KR950701224A (ko) 1995-03-23
JPH07506366A (ja) 1995-07-13
HU9403108D0 (en) 1995-02-28
FI945081A7 (fi) 1994-10-28
NO307594B1 (no) 2000-05-02
NO944113L (no) 1994-10-28

Similar Documents

Publication Publication Date Title
FI945081A7 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformu laatioon
IL106927A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
DE69428743D1 (de) Trockenpulverinhalator
IL103748A (en) 2-substituted saccharin derivatives and pharmaceutical compositions containing them
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
FI950402L (fi) Oraaliset koostumukset
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
NZ201833A (en) Thieno-and furopyridinium-substituted cephalosporin derivatives and pharmaceutical compositions
FI953887A7 (fi) Kefaklorin farmaseuttisia formulaatioita
IL103818A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL119215A0 (en) Cephalosporin derivatives their manufacture and pharmaceutical compositions containing them
FI896224A7 (fi) Kefalosporiiniyhdisteet
NZ222407A (en) 3-substituted cephalosporin derivatives and pharmaceutical compositions
DE69222599D1 (de) Cephalosporin-Derivate
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
DE69314072D1 (de) Cephalosporin-Derivat
IL97288A0 (en) Photosensitive formulations containing carbodiimide derivatives and processes for the preparation thereof
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions
FI934387A7 (fi) 3-substituoituja 2-oksi-indoli-1-karboksiamidia käsittäviä farmaseuttisia koostumuksia
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ225383A (en) Cephalosporin derivatives and pharmaceutical compositions
DE69532476D1 (de) Benetzbare pulverformulierungen
EP0492277A3 (en) Cephalosporin derivatives
NZ224997A (en) Cephalosporin derivatives and pharmaceutical compositions